{"id":"W2139142789","doi":"10.1093/annonc/mdm592","title":"A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer","year":2008,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":false,"ca_institutions":"Eli Lilly (Canada); Alberta Cancer Foundation","funders":"U.S. Food and Drug Administration","keywords":"Pemetrexed; Medicine; Hazard ratio; Lung cancer; Internal medicine; Interim analysis; Confidence interval; Oncology; Chemotherapy; Toxicity; Randomized controlled trial; Surgery; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001903542,0.0002394852,0.001619618,0.0002048872,0.00006858262,0.000005163818,0.0000461784,0.00005984229,0.0002491487],"category_scores_gemma":[0.00005682315,0.0001470978,0.00009790785,0.0002069544,0.0001667491,0.00008257345,0.00002026091,0.00009503452,0.0000011716],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002443836,"about_ca_system_score_gemma":0.001402935,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001180255,"about_ca_topic_score_gemma":0.001806006,"domain_scores_codex":[0.9984839,0.0001303097,0.0006013859,0.0003083361,0.0001913973,0.0002846528],"domain_scores_gemma":[0.998746,0.0003088615,0.0003424395,0.0001739845,0.0002658016,0.0001629607],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9650739,0.004691476,0.004678301,0.0000977956,0.001302648,0.0002097532,0.002089356,0.0001789217,0.00004506592,0.00001037219,0.0001492771,0.02147313],"study_design_scores_gemma":[0.9622555,0.03182391,0.001956376,0.0001285852,0.001156783,0.00001091357,0.0001552765,0.0003379409,0.001259973,0.00001359743,0.0007597404,0.0001414055],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929373,0.0009203717,0.0001620261,0.000452164,0.0001236148,0.004427797,0.00008418396,0.00001517145,0.0008773751],"genre_scores_gemma":[0.9948964,0.001144991,0.00174051,0.0003600765,0.00003615744,0.0007545454,0.0001199851,0.00002397741,0.0009233577],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02713244,"threshold_uncertainty_score":0.5998474,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05161190808332462,"score_gpt":0.4126153450498675,"score_spread":0.3610034369665429,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}